Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 805% % 44%
Debt-to-equity 29% % -40%
Return On Equity -7.3% % 84%
Return On Assets -5.7% % 82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101,856,245 shares 1.3%
Common Stock, Shares, Outstanding 101,748,962 shares 22%
Entity Public Float $1,700,000,000 USD -11%
Common Stock, Value, Issued $1,017,000 USD 22%
Weighted Average Number of Shares Outstanding, Basic 98,905,577 shares 20%
Weighted Average Number of Shares Outstanding, Diluted 98,905,577 shares 20%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $139,743,000 USD 120%
Research and Development Expense $409,618,000 USD 11%
General and Administrative Expense $113,818,000 USD 2.1%
Operating Income (Loss) $383,693,000 USD 7.7%
Nonoperating Income (Expense) $303,701,000 USD 681%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $112,728,000 USD -17%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $79,992,000 USD 79%
Earnings Per Share, Basic -0.81 USD/shares 82%
Earnings Per Share, Diluted -0.81 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $294,944,000 USD 4.6%
Marketable Securities, Current $950,266,000 USD 67%
Cash, Cash Equivalents, and Short-term Investments $1,200,000,000 USD 41%
Assets, Current $1,268,688,000 USD 44%
Property, Plant and Equipment, Net $104,500,000 USD -6.2%
Operating Lease, Right-of-Use Asset $100,679,000 USD -4%
Other Assets, Noncurrent $634,000 USD -49%
Assets $1,481,177,000 USD 34%
Accounts Payable, Current $10,231,000 USD 164%
Employee-related Liabilities, Current $29,342,000 USD 36%
Contract with Customer, Liability, Current $6,659,000 USD -94%
Liabilities, Current $96,935,000 USD -47%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $139,759,000 USD -5.5%
Other Liabilities, Noncurrent $173,000 USD -66%
Liabilities $242,819,000 USD -34%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,111,000 USD 64%
Retained Earnings (Accumulated Deficit) $1,641,219,000 USD -4.8%
Stockholders' Equity Attributable to Parent $1,238,358,000 USD 69%
Liabilities and Equity $1,481,177,000 USD 34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $103,884,000 USD -4.1%
Net Cash Provided by (Used in) Financing Activities $473,379,000 USD 16240%
Net Cash Provided by (Used in) Investing Activities $125,089,000 USD -134%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 101,748,962 shares 22%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $244,406,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $301,620,000 USD 4%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $455,329,000 USD 3.9%
Deferred Tax Assets, Gross $484,332,000 USD 3.3%
Operating Lease, Liability $154,123,000 USD -4.5%
Depreciation $22,294,000 USD 1.7%
Payments to Acquire Property, Plant, and Equipment $3,065,000 USD 26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $79,560,000 USD 79%
Lessee, Operating Lease, Liability, to be Paid $210,141,000 USD -7.7%
Property, Plant and Equipment, Gross $198,627,000 USD 8.2%
Operating Lease, Liability, Current $14,364,000 USD 6.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $25,436,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year One $24,727,000 USD 1.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.073 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $56,018,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $25,664,000 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $141,126,000 USD 188%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $22,147,000 USD -5.2%
Additional Paid in Capital $2,877,449,000 USD 25%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $5,528,000 USD 1.8%
Share-based Payment Arrangement, Expense $94,244,000 USD -22%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%